February 14, 2023
FDA: Class I recall of Skippack Medical Lab COVID-19 tests
Editor's Note
The Food and Drug Administration (FDA) on February 8 identified the recall by Universal Meditech Inc of its Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold) as Class I, the most serious.
The recall was initiated because the tests were distributed to US customers without authorization, clearance, or approval from the FDA.
Distribution dates were January 2022.
Free Daily News
- Biden administration expands HHS authority to bolster US medical supply chain
- FTC lawsuit challenges private equity medical group ‘Roll-Up’ deals
- Functional ultrasound offers less invasive option for people with paralysis
- Balanced IV solutions may benefit critically ill patients
- ASCs continue to contend with anesthesia provider shortages, inflating costs
- Study: VR technology helps reduce patient anxiety prior to surgery
- Researchers develop new early stage breast cancer detection device
- Proposed bill seeks to end costly insurance fees on electronic healthcare payments
- Research indicates CAB sequence yields best results in trauma patients
- Stronger quads shown to reduce need for knee replacement surgery
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity, Equity, Inclusion & Belonging